Evaluation of a Human Acellular Dermal Matrix in Post Mastectomy Reconstruction

NCT02263261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-09-20

No results posted yet for this study

Summary

Use of a HADM and implant in post-mastectomy breast reconstruction.

Conditions

  • Mastectomy
  • Breast Reconstruction

Interventions

OTHER

Flex HD Pliable Perforated HADM

Human Acellular Dermal Matrix

Sponsors & Collaborators

  • Musculoskeletal Transplant Foundation

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-06-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02263261 on ClinicalTrials.gov